INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "ENGINEERED IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS TARGETING TROP2 AND METHODS OF USING THE SAME"

GENEVA, Sept. 22 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215-5450) filed a patent application (PCT/US2025/020032) for "ENGINEERED IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS TARGETING TROP2, AND METHODS OF USING THE SAME" on Mar 14, 2025. With publication no. WO/2025/194098, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SMITH, Eric (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, Massachusetts 02215-5450), BREA, Elliott (c/o Dana-Farber Cancer Institute...